Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The proliferation-stimulating transactivator FOXM1c (MPP2) is repressed by RB and activated by cyclin D1/Cdk4 and therefore behaves like E2F. Despite its strong transactivation domain, FOXM1c is kept almost inactive by two different inhibitory domains, the N-terminus and the central domain. The tumor suppressor RB binds directly to the central domain of FOXM1c and thereby indirectly represses the transactivation domain, so that the central domain of FOXM1c functions as an RB-recruiting negative-regulatory domain. Cyclin D1/Cdk4 releases FOXM1c from this repression by RB and from the repression by its own inhibitory N-terminus, thereby strongly activating FOXM1c. However, cyclin D1/Cdk4 does not directly affect the transactivation domain or the DNA-binding domain. By phosphorylation of RB, but not FOXM1c, cyclin D1/Cdk4 interrupts their direct interaction and thus abrogates the repression of FOXM1c by RB. Cyclin D1/Cdk4 also eliminates the inhibition of the transactivation domain by the N-terminus of FOXM1c, probably by interruption of their direct interaction. Consequently, the G1-phase proliferation signal cyclin D1/Cdk4 converts FOXM1c from an almost inactive form into a strong transactivator in G1-phase, i.e., just at the time point at which the transcriptional activity of FOXM1 is required for stimulation of the G1/S-transition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
G 1 Events and Regulation of Cell Proliferation
Pardee, A. B. (1989) · Science · doi:10.1126/science.2683075 · Cited by 2,182
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690 · cited 19×
“…these IDs to exclude its aberrant activity and thus to prevent aberrant stimulation of proliferation, because deregulated proliferation can result in tumorigenesis (Hanahan and Weinberg, 2000; Evan and Vousden, 2001; Malumbres and Barbacid, 2001; Hahn and Weinberg, 2002; Sherr and McCormick, 2002).”
BackgroundInfluentialSibling rivalry in the E2F family
Trimarchi, J. M., & Lees, J. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm714 · Cited by 1,158 · cited 5×
“RB binds to E2F and represses the expression of E2F target genes (Qin et al., 1992; Hiebert, 1993; Adams and Kaelin, 1995; Dyson, 1998; Trimarchi and Lees, 2002).”
BackgroundInfluentialThe Rb/E2F pathway: expanding roles and emerging paradigms
Harbour, J. W., & Dean, D. C. (2000) · Genes & Development · doi:10.1101/gad.813200 · Cited by 1,153
Living with or without cyclins and cyclin-dependent kinases
Sherr, C. J., & Roberts, J. M. (2004) · Genes & Development · doi:10.1101/gad.1256504 · Cited by 1,089 · cited 4×
“The cell cycle is controlled by the consecutive action of different cyclin/Cdk complexes, the activity of which is tightly regulated by diverse mechanisms (Sherr and Roberts, 1999, 2004; Obaya and Sedivy, 2002; Ciemerych and Sicinski, 2005).”
BackgroundInfluentialThe retinoblastoma tumour suppressor in development and cancer
Classon, M., & Harlow, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc950 · Cited by 738 · cited 3×
“…of E2F (Adams and Kaelin, 1995; Weinberg, 1995; Ezhevsky et al., 1997; Dyson, 1998; Lundberg and Weinberg, 1998; Harbour et al., 1999; Sherr and Roberts, 1999; Harbour and Dean, 2000; Zhang et al., 2000; Adams, 2001; Sherr, 2001; Classon and Harlow, 2002; Sherr and McCormick, 2002; Cobrinik, 2005).”
BackgroundThe E2F transcriptional network: old acquaintances with new faces
Dimova, D. K., & Dyson, N. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208612 · Cited by 715 · cited 5×
“After its phosphorylation by cyclin D1(D2,D3)/Cdk4(6) and cyclin E/Cdk2, RB is released from E2F, so that the E2F target genes required for G1/S transition and S-phase are activated (DeGregori, 2002; Cam and Dynlacht, 2003; Blais and Dynlacht, 2004; Bracken et al., 2004; Dimova and Dyson, 2005).”
BackgroundInfluentialZhang, H. S., Gavin, M., Dahiya, A., Postigo, A. A., Ma, D., Luo, R. X., Harbour, J. W., & Dean, D. C. (2000) · Cell · doi:10.1016/s0092-8674(00)80625-x · Cited by 658
Wang, I.-C., Chen, Y.-J., Hughes, D., Petrovic, V., Major, M. L., Park, H. J., Tan, Y., Ackerson, T., & Costa, R. H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.10875-10894.2005 · Cited by 627
Pocket proteins and cell cycle control
Cobrinik, D. (2005) · Oncogene · doi:10.1038/sj.onc.1208619 · Cited by 601 · cited 4×
“…of E2F (Adams and Kaelin, 1995; Weinberg, 1995; Ezhevsky et al., 1997; Dyson, 1998; Lundberg and Weinberg, 1998; Harbour et al., 1999; Sherr and Roberts, 1999; Harbour and Dean, 2000; Zhang et al., 2000; Adams, 2001; Sherr, 2001; Classon and Harlow, 2002; Sherr and McCormick, 2002; Cobrinik, 2005).”
BackgroundInfluentialSellers, W. R., Novitch, B. G., Miyake, S., Heith, A., Otterson, G. A., Kaye, F. J., Lassar, A. B., & Kaelin, W. G. (1998) · Genes & Development · doi:10.1101/gad.12.1.95 · Cited by 343
Growth hormone stimulates proliferation of old-aged regenerating liver through forkhead box m1b
Krupczak-Hollis, K. (2003) · Hepatology · doi:10.1053/jhep.2003.08052 · Cited by 115 · cited 6×
“…progression by RB and cyclin D1/Cdk4 if the function of E2F-1, E2F-2 and E2F-3 or cyclin E/Cdk2 is impossible or reduced, as well as under particular physiological conditions, e.g., during regenerative liver proliferation in aged animals (Wang et al., 2001b, 2002a; Krupczak-Hollis et al., 2003).”
BackgroundInfluential
Cited by
The emerging roles of forkhead box (Fox) proteins in cancer
Myatt, S. S., & Lam, E. W. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2223 · Cited by 1,070
Forkhead box proteins: tuning forks for transcriptional harmony.
Lam, E. W.-F., Brosens, J. J., Gomes, A. R., & Koo, C.-Y. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3539 · Cited by 684
Anders, L., Ke, N., Hydbring, P., Choi, Y. J., Widlund, H. R., Chick, J. M., Zhai, H., Vidal, M., Gygi, S. P., Braun, P., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.001 · Cited by 543
“At the same time, phosphorylation directly activates FOXM1 transcriptional function, consistent with previous observations that cyclin D1-CDK4 strongly activates FOXM1 in reporter gene assays (Wierstra and Alves, 2006), as does cyclin E-CDK2, although to a lesser extent (Lüescher-Firzlaff et al.”
InfluentialRegulation of the master regulator FOXM1 in cancer
Liao, G.-B., Li, X.-Z., Zeng, S., Liu, C., Yang, S.-M., Yang, L., Hu, C.-J., & Bai, J.-Y. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0266-6 · Cited by 417
Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma
Rader, J., Russell, M. R., Hart, L. S., Nakazawa, M. S., Belcastro, L. T., Martinez, D., Li, Y., Carpenter, E. L., Attiyeh, E. F., Diskin, S. J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1675 · Cited by 394
Metadata
- Authors
- Wierstra, I., & Alves, J.
- Venue
- Biological Chemistry
- Publisher
- Walter de Gruyter GmbH
- Published
- 2006-01-01
- Volume
- 387
- Issue
- 7
- Pages
- 949-62
- ISSN
- 1431-6730 (ISSN-L)
- 1437-4315
- OpenAlex
- W1978521623
- Cited by
- 68
- References
- 13
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.